Long-term intravenous administration of activated autologous lymphocytes for cancer patients does not induce antinuclear antibody and rheumatoid factor.

Tomohiro Yamaguchi, Kohtaro Yamamoto, Yasuyuki Kuroiwa et al.|PubMed|2004

Cited by 7